The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1212

I don't disagree, but at the end of the day MT isn't the only CEO in the world to do good promotion. Maybe the next bloke will be even better! I must say I agree with all who think the way it has been handled and shared has been somewhat disappointing - it's as though PAA don't mind because they know the drug is sold as soon as ODD is announced perhaps? Maybe MT has handed in his notice because he won't be working for the company that is buying out PAA? Who knows really, other than like you say, we do know the existing path will provide the opportunity for MPL to demonstrate it's success.